Mark Eisner, EVP and Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 10,382 shares at $5.47 ($57K) on 2025-07-17, disclosed to the SEC on 2025-07-17.
Scheduled sale ($57k) by EVP and Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.47 | 6,796 | $37K | 65.5% |
| 2 | $5.47 | 3,586 | $20K | 34.5% |
| Total | $5.47 avg | 10,382 | $57K | 100% |
| Filing → |
| FGEN | SELL | 2023-06-09 | $35K | — | Filing → |
| FGEN | SELL | 2023-06-05 | $21K | — | Filing → |
| FGEN | SELL | 2023-04-06 | $345K | — | Filing → |